Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2915 ARTíCULOS , VIENDO DEL 136 AL 150

PUBMED

Artistic occupations are associated with a reduced risk of Parkinson's disease.

Haaxma CA, Borm GF, van der Linden D, Kappelle AC, Bloem BR.

J Neurol. 2015 Sep;262(9):2171-6. doi: 10.1007/s00415-015-7828-y.

0

0

0

PUBMED

Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson's disease.

Gulberti A, Hamel W, Buhmann C, Boelmans K, Zittel S, Gerloff C, Westphal M, Engel AK, Schneider TR, Moll CK.

Clin Neurophysiol. 2015 Mar;126(3):565-74. doi: 10.1016/j.clinph.2014.06.046.

0

0

0

PUBMED

Challenges and strategies of medication adherence in Parkinson's disease: A qualitative study.

Shin JY, Habermann B, Pretzer-Aboff I.

Geriatr Nurs. 2015 May-Jun;36(3):192-6. doi: 10.1016/j.gerinurse.2015.01.003.

0

0

0

PUBMED

Syntax, action verbs, action semantics, and object semantics in Parkinson's disease: Dissociability, progression, and executive influences.

Bocanegra Y, García AM, Pineda D, Buriticá O, Villegas A, Lopera F, Gómez D, Gómez-Arias C, Cardona JF, Trujillo N, Ibáñez A.

Cortex. 2015 Aug;69:237-54. doi: 10.1016/j.cortex.2015.05.022.

0

0

0

PUBMED

Prevalence and clinical correlates of drooling in Parkinson disease: a study on 518 Chinese patients.

Ou R, Guo X, Wei Q, Cao B, Yang J, Song W, Shao N, Zhao B, Chen X, Shang H.

Parkinsonism Relat Disord. 2015 Mar;21(3):211-5. doi: 10.1016/j.parkreldis.2014.12.004.

0

0

0

PUBMED

Habitual behavior and dopamine cell vulnerability in Parkinson disease.

Hernández LF, Redgrave P, Obeso JA.

Front Neuroanat. 2015 Aug 6;9:99. doi: 10.3389/fnana.2015.00099. No abstract available. Erratum in: Front Neuroanat. 2015;9:146.

0

0

0

PUBMED

Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease.

Thornton E, Vink R.

Neural Regen Res. 2015 Sep;10(9):1403-5. doi: 10.4103/1673-5374.165505. No abstract available.

0

0

0

PUBMED

Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).

Storch A, Schneider CB, Klingelhöfer L, Odin P, Fuchs G, Jost WH, Martinez-Martin P, Koch R, Reichmann H, Chaudhuri KR; NoMoFlu-PD study group., Ebersbach G.

J Neural Transm (Vienna). 2015 Dec;122(12):1673-84. doi: 10.1007/s00702-015-1437-x.

0

0

0

PUBMED

Classification of Parkinson's Disease Gait Using Spatial-Temporal Gait Features.

Wahid F, Begg RK, Hass CJ, Halgamuge S, Ackland DC.

IEEE J Biomed Health Inform. 2015 Nov;19(6):1794-802. doi: 10.1109/JBHI.2015.2450232.

0

0

0

PUBMED

Longitudinal study of the substantia nigra in Parkinson disease: A high-field (1) H-MR spectroscopy imaging study.

Seraji-Bozorgzad N, Bao F, George E, Krstevska S, Gorden V, Chorostecki J, Santiago C, Zak I, Caon C, Khan O.

Mov Disord. 2015 Sep;30(10):1400-4. doi: 10.1002/mds.26323.

0

0

0

PUBMED

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Schrag A, Horsfall L, Walters K, Noyce A, Petersen I.

Lancet Neurol. 2015 Jan;14(1):57-64. doi: 10.1016/S1474-4422(14)70287-X.

0

0

0

PUBMED

Parkinson disease: How reliable are prodromal indicators of Parkinson disease?

Silveira-Moriyama L, Lees AJ.

Nat Rev Neurol. 2015 Jan;11(1):5-6. doi: 10.1038/nrneurol.2014.235. No abstract available.

0

0

0

PUBMED

Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria.

Jain S, Himali J, Beiser A, Ton TG, Kelly-Hayes M, Biggs ML, Delaney JA, Rosano C, Seshadri S, Frank SA.

Am J Epidemiol. 2015 Feb 1;181(3):185-90. doi: 10.1093/aje/kwu326.

0

0

0

PUBMED

Pilot study of atomoxetine in patients with Parkinson's disease and dopa-unresponsive Freezing of Gait.

Revuelta GJ, Embry A, Elm JJ, Gregory C, Delambo A, Kautz S, Hinson VK.

Transl Neurodegener. 2015 Dec 10;4:24. doi: 10.1186/s40035-015-0047-8.

0

0

0

PUBMED

The endosomal pathway in Parkinson's disease.

Perrett RM, Alexopoulou Z, Tofaris GK.

Mol Cell Neurosci. 2015 May;66(Pt A):21-8. doi: 10.1016/j.mcn.2015.02.009. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy